Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Lymphoblastic Leukemia
Study data from Children's National Medical Center update knowledge of acute lymphoblastic leukemia in children
April 13th, 2008
Data detailed in 'Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group' have been presented. "Longer and more intensive postinduction intensification (PII) improved the outcome of children and adolescents with 'higher risk' acute lymphoblastic leukemia (ALL) and a slow marrow response to induction therapy. In the Children's Cancer Group study (CCG-1961), we tested longer versus more intensive PII, using a 2 x 2 factorial design for children with higher risk ALL and a rapid marrow response to induction therapy," researchers in the United States report....
Source: Pharma Investments, Ventures & Law Weekly (2008-04-13)
|
|
Advertisement |
|
|
|
